The Cambridge Biomedical Campus, located at the southern end of Hills Road on the southern edge of Cambridge, England, is the largest centre of health science and medical research in Europe. Managed by the University of Cambridge, the site is funded by organisations such as the Cambridge University Hospitals NHS Foundation Trust, the Wellcome Trust, Cancer Research UK, the UK government's Medical Research Council and has National Institute for Health Research Biomedical Research Centre status. It is an accredited UK academic health science centre (Cambridge University Health Partners) and home to Addenbrooke's Hospital and the university's medical school.
The Cambridge Biomedical Campus is home to the following institutes.
Addenbrooke's Hopital is a large teaching hospital, and the central focus of the campus.
AstraZeneca’s global research and development facility is due to be based on the campus and will house a workforce of approximately 2,000 individuals. It will be home to both early and late-stage medicines discovery and development, and cover both small molecules and biologics. Research activities will span all preclinical functional groups, including antibody engineering, medicinal chemistry and high throughput screening.
The LMB is a molecular biology research institute funded by the UK Medical Research Council. It was founded in Cambridge in 1947 as the Unit for Research on the Molecular Structure of Biological Systems and moved to a site adjacent to Addenbrooke's Hospital in 1962. A 27,000m2 replacement building close to the previous site was completed in 2012 and opened in May 2013.